Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Burtness, Barbara, Greil, Richard, de Castro, Gilberto, Fuereder, Thorsten, Ngamphaiboon, Nuttapong, Wan Ishak, Wan Zamaniah, Hong, Ruey-Long, González Mendoza, René, Zhang, Yayan, Gumuscu, Burak, Boyer, Michael, Hughes, Brett, Rischin, Danny, Taylor, Anne, Burian, Martin, Barrios, Carlos Henrique, de Castro Junior, Dalvaro Oliveira, Franke, Fabio Andre, Girotto, Gustavo, Lima, Iane Pinto Figueiredo, Nicolau, Ulisses Ribaldo, Santos, Lucas, Victorino, Ana-Paula, Chua, Neil, Couture, Felix, Hansen, Aaron, Hilton, John, McCarthy, Joy, Soulieres, Denis, Ascui, Rodrigo, Villanueva, Luis, Kral, Zdenek, Prausova, Jana, Vosmik, Milan, Jurgens, Hannes, Putnik, Kadri, Gruenwald, Viktor, Boukovinas, Ioannis, Psyrri, Amanda, Kwong, Dora, Csoszi, Tibor, Horvai, Geza, Landherr, Laszlo, Szota, Judit, Billan, Salem, Nole, Franco, Fujimoto, Yasushi, Hanai, Nobuhiro, Hara, Hiroki, Shimizu, Yasushi, Sugasawa, Masashi, Takahashi, Shunji, Tanaka, Kaoru, Ueda, Tsutomu, Wan Ishak, Wan Zamaniah, Gonzalez Mendoza, Rene, Buter, Jan, Hoeben, Ann, Bratland, Aase, Querol, John, Regala, Eugenio Emmanuel, Villegas, Ellie May, Karpenko, Andrey, Zarubenkov, Oleg, Cohen, Graham, du Toit, Johanna, Jordaan, Christa, Landers, Gregory, Ruff, Paul, Tabane, Neonyana, Brana, Irene, Iglesias Docampo, Lara, Abel, Edvard, Muratidu, Valentina, Nielsen, Niels, Cristina, Valerie, Rothschild, Sacha, Yang, Muh-Hwa, Yeh, Su-Peng, Ngamphaiboon, Nuttapong, Cicin, Irfan, Ekenel, Meltem, Harrington, Kevin, Ali, Haythem, Anderson, Daniel, Bruce, Justine, Halmos, Balazs, Hegde, Upendra, Khan, Saad, Martincic, Danko, McCune, Steven, Misiukiewicz, Krzysztof, Neupane, Prakash, Nunnink, Johannes, O'Malley, Meaghan, Powell, Steven, Redman, Rebecca, Rella, Vincent, Rocha Lima, Chaio, Wong, Stuart
Published in The Lancet (British edition) (23.11.2019)
Published in The Lancet (British edition) (23.11.2019)
Get full text
Journal Article
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer
Capdevila, Jaume, Klochikhin, Arkadiy, Leboulleux, Sophie, Isaev, Pavel, Badiu, Corin, Robinson, Bruce, Hughes, Brett G M, Keam, Bhumsuk, Parnis, Francis, Elisei, Rossella, Gajate, Pablo, Gan, Hui K, Kapiteijn, Ellen, Locati, Laura, Mangeshkar, Milan, Faoro, Leonardo, Krajewska, Jolanta, Jarzab, Barbara
Published in Thyroid (New York, N.Y.) (01.05.2022)
Published in Thyroid (New York, N.Y.) (01.05.2022)
Get full text
Journal Article
KEYNOTE-689: A Phase 3 Study of Neoadjuvant and Adjuvant Pembrolizumab Plus Standard of Care (SOC) in Resectable, Locally Advanced (LA) Head and Neck Squamous Cell Carcinoma (HNSCC)
Klochikhin, Arkadiy, Haddad, Robert I., Meirovitz, Amichay, Safina, Sufia, Brana, Irene, Le Tourneau, Christophe, Uppaluri, Ravindra, Lee, Nancy Y., Cohen, Ezra E.W., Chernock, Rebecca, Westra, William, Liu, Hong, Gumuscu, Burak, Benjamin, Kimberly, Adkins, Douglas
Published in European journal of surgical oncology (01.01.2023)
Published in European journal of surgical oncology (01.01.2023)
Get full text
Journal Article
Abstract CT285: KEYNOTE-689: A phase 3 study of neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC)
Lee, Nancy Y., Uppaluri, Ravindra, Westra, William, Cohen, Ezra E., Haddad, Robert I., Temam, Stephane, Le Tourneau, Christophe, Chernock, Rebecca, Safina, Sufia, Klochikhin, Arkadiy, Meirovitz, Amichay, Brana, Irene, Ge, Joy Yang, Swaby, Ramona F., Pinheiro, Cecilia, Adkins, Douglas
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
KEYNOTE-689: Phase 3 study of adjuvant and neoadjuvant pembrolizumab combined with standard of care (SOC) in patients with resectable, locally advanced head and neck squamous cell carcinoma
Uppaluri, Ravindra, Lee, Nancy Y., Westra, William, Cohen, Ezra E.W., Haddad, Robert I., Temam, Stephane, Le Tourneau, Christophe, Chernock, Rebecca, Safina, Sufia, Klochikhin, Arkadiy, Meirovitz, Amichay, Braña, Irene, Ge, Joy Yang, Swaby, Ramona F., Bidadi, Behzad, Adkins, Douglas
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Abstract PO-002: Pembrolizumab as neoadjuvant and adjuvant therapy in combination with standard of care in resectable, locally advanced head and neck squamous cell carcinoma: Phase 3 KEYNOTE-689
Klochikhin, Arkadiy, Haddad, Robert I., Meirovitz, Amichay, Safina, Sufia, Brana, Irene, Tourneau, Christophe Le, Uppaluri, Ravindra, Lee, Nancy Y., Cohen, Ezra E. W., Chernock, Rebecca, Westra, William, Liu, Hong, Gumuscu, Burak, Benjamin, Kimberly, Adkins, Douglas
Published in Clinical cancer research (15.09.2023)
Published in Clinical cancer research (15.09.2023)
Get full text
Journal Article